Skip to main content
ESPR
ESPR logo

ESPR · Esperion Therapeutics, Inc.

Track ESPR — free
Market Cap
$818.63M
Shares
257.43M
All earnings calls

Earnings call · FY2019 Q4

Esperion Therapeutics, Inc. Q4 FY2019 Earnings Call

Esperion Therapeutics, Inc. Q4 FY2019 Earnings Call

Concluded Feb 27, 2020
Feb 27, 2020 0 turns
Period
FY2019 Q4
Runtime
Sources
2 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Research coverage

2 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $982,000
Diluted EPS -$2.26
Net income -$61.95M

Research materials

Open the source you need; every reader stays inside this workspace.

Full-screen source Call document